Formation of F-ring isoprostane-like compounds (F3-isoprostanes) in vivo from eicosapentaenoic acid.
Eicosapentaenoic acid (EPA, C20:5, omega-3) is the most abundant polyunsaturated fatty acid (PUFA) in fish oil. Recent studies suggest that the beneficial effects of fish oil are due, in part, to the generation of various free radical-generated non-enzymatic bioactive oxidation products from omega-3 PUFAs, although the specific molecular species responsible for these effects have not been identified. Our research group has previously reported that pro-inflammatory prostaglandin F2-like compounds, termed F2-isoprostanes (IsoPs), are produced in vivo by the free radical-catalyzed peroxidation of arachidonic acid and represent one of the major products resulting from the oxidation of this PUFA. Based on these observations, we questioned whether F2-IsoP-like compounds (F3-IsoPs) are formed from the oxidation of EPA in vivo. Oxidation of EPA in vitro yielded a series of compounds that were structurally established to be F3-IsoPs using a number of chemical and mass spectrometric approaches. The amounts formed were extremely large (up to 8.7 + 1.0 microg/mg EPA) and greater than levels of F2-IsoPs generated from arachidonic acid. We then examined the formation of F3-IsoPs in vivo in mice. Levels of F3-IsoPs in tissues such as heart are virtually undetectable at baseline, but supplementation of animals with EPA markedly increases quantities up to 27.4 + 5.6 ng/g of heart. Interestingly, EPA supplementation also markedly reduced levels of pro-inflammatory arachidonate-derived F2-IsoPs by up to 64% (p < 0.05). Our studies provide the first evidence that identify F3-IsoPs as novel oxidation products of EPA that are generated in vivo. Further understanding of the biological consequences of F3-IsoP formation may provide valuable insights into the cardioprotective mechanism of EPA.
Gao
Ling
L
Division of Clinical Pharmacology, Department of Medicine, Vanderbilt University, Nashville, Tennessee 37232, USA.
Yin
Huiyong
H
Milne
Ginger L
GL
Porter
Ned A
NA
Morrow
Jason D
JD
D000818:Animals; D016718:Arachidonic Acid / Q000378:metabolism; D002384:Catalysis; D015237:Dinoprost / Q000737:chemistry*; D015777:Eicosanoids / Q000737:chemistry; D015118:Eicosapentaenoic Acid / Q000737:chemistry*; D005609:Free Radicals; D007249:Inflammation; D028421:Isoprostanes / Q000737:chemistry*; D051379:Mice; D008956:Models, Chemical; D009206:Myocardium / Q000378:metabolism; D010100:Oxygen / Q000378:metabolism; D011485:Protein Binding
D015777:Eicosanoids; D005609:Free Radicals; D028421:Isoprostanes; D016718:Arachidonic Acid; D015118:Eicosapentaenoic Acid; D015237:Dinoprost; D010100:Oxygen